Vaccine Treatment for Ebola Virus in Healthy Adults (V920-001)

NCT02269423 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

39

Enrollment

INDUSTRY

Sponsor class

Conditions

Ebola Virus

Interventions

BIOLOGICAL: V920
OTHER: Placebo

Sponsor

Merck Sharp & Dohme LLC

Collaborators

[object Object]
[object Object]